Dr. Nelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5200 Centre Ave
Ste 209
Pittsburgh, PA 15232Phone+1 412-605-3000Fax+1 412-605-3030
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Urology, 1989 - 1994
- McGaw Medical Center of Northwestern UniversityInternship, Transitional Year, 1988 - 1989
- Northwestern University The Feinberg School of MedicineClass of 1988
Certifications & Licensure
- PA State Medical License 1993 - 2024
- OH State Medical License 1992 - 2022
- MD State Medical License 1994 - 1999
- IL State Medical License 1988 - 1996
- American Board of Urology Urology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases Start of enrollment: 2007 Nov 01
Publications & Presentations
PubMed
- 584 citationsGene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of MalignancyYan Ping Yu, Douglas Landsittel, Ling Jing, Joel B. Nelson, Baoguo Ren
Journal of Clinical Oncology. 2004-07-15 - 181 citationsConcurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.Juan Miguel Mosquera, Himisha Beltran, Kyung Park, Theresa Y. MacDonald, Brian D. Robinson
Neoplasia. 2013-01-01 - 944 citationsA Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.Jonathan I. Epstein, Michael J. Zelefsky, Daniel Sjöberg, Joel B. Nelson, Lars Egevad
European Urology. 2016-03-01
Press Mentions
- UPMC HealthBeat Podcast: Managing Prostate CancerJune 19th, 2020
- UPMC Names Robert Bart CMIO, Will Focus on Health Records, Clinical TechJune 2nd, 2017
- More Than Three Percent of Men on Active Surveillance for Prostate Cancer May Have MetastasesApril 11th, 2016
Grant Support
- Androgen Signaling In Benign Prostatic Hyperplasia (BPH)National Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
- Conference--Prouts Neck Prostate CancerNational Cancer Institute2004–2005
- Endothelin B Receptor And Prostate CancerNational Cancer Institute1999–2001
- Endothelin B Receptor And Prostate CancerNational Cancer Institute1997–1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: